Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review

References

• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-9
   PubMed Web of Science ®Google Scholar
• Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–3245. doi:10.1093/eurheartj/ehw334
   PubMed Web of Science ®Google Scholar
• Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;2999–3058. doi:10.1093/eurheartj/ehw272
   Web of Science ®Google Scholar
• Sabaté E; World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Vol. xv. World Health Organization; 2003:198. Available from: http://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf;jsessionid=28AA4EDC4BD4B97052696A4F4990D5D0?sequence=1. Accessed Aug 17, 2021.
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. Review. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–7.e1. doi:10.1016/j.amjmed.2011.12.013
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• De Vera MA, Bhole V, Burns LC, Lacaille D. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014;78(4):684–698. doi:10.1111/bcp.12339
   PubMed Web of Science ®Google Scholar
• Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013;126(4):357.e7–357.e27. doi:10.1016/j.amjmed.2012.09.004
   Web of Science ®Google Scholar
• Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi:10.1093/eurheartj/eht295
   PubMed Web of Science ®Google Scholar
• Carvalho AS, Santos P. Medication adherence in patients with arterial hypertension: the relationship with healthcare systems’ organizational factors. Original. Patient Prefer Adherence. 2019;13:1761–1774. doi:10.2147/PPA.S216091
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [internet]. National Institutes of Health; 2021 [cited 2021 Mar 31] Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed August 23, 2021.
   Google Scholar
• Kiortsis DN, Giral P, Bruckert E, Turpin G. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther. 2000;25(6):445–451. doi:10.1046/j.1365-2710.2000.00315.x
   PubMed Web of Science ®Google Scholar
• Mansur AP, Mattar APL, Tsubo CE, Simão DT, Yoshi FR, Daci K. Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. Article. Arq Bras Cardiol. 2001;76(2):111–118. doi:10.1590/S0066-782X2001000200002
   Google Scholar
• O’Donnell DC, Brown CM, Piziak VK. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic. Note. Ame J Health Syst Pharm. 2001;58(11):1017–1021. doi:10.1093/ajhp/58.11.1017
   Web of Science ®Google Scholar
• Yang CC, Jick SS, Testa MA. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics. Br J Clin Pharmacol. 2003;56(1):84–91. doi:10.1046/j.1365-2125.2003.01818.x
   PubMed Web of Science ®Google Scholar
• Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27(2):117–124. doi:10.1207/s15324796abm2702_6
   PubMed Web of Science ®Google Scholar
• Benner JS, Pollack MF, Smith TW, Bullano MF, Willey VJ, Williams SA. Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. Am J Health Syst Pharm. 2005;62(14):1468–1475. doi:10.2146/ajhp040419
   Web of Science ®Google Scholar
• Caspard H, Chan AK, Walker AM. Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clin Ther. 2005;27(10):1639–1646. doi:10.1016/j.clinthera.2005.10.005
   Web of Science ®Google Scholar
• Di Martino M, Degli Esposti L, Ruffo P, et al. Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy. Eur J Clin Pharmacol. 2005;61(3):225–230. doi:10.1007/s00228-005-0911-z
   Web of Science ®Google Scholar
• Huser MA, Evans TS, Berger V. Medication adherence trends with statins. Article. Adv Ther. 2005;22(2):163–171. doi:10.1007/BF02849887
   Web of Science ®Google Scholar
• Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res. 2007;7:175. doi:10.1186/1472-6963-7-175
   PubMed Web of Science ®Google Scholar
• McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41(11):1805–1811. doi:10.1345/aph.1K209
   Web of Science ®Google Scholar
• Natarajan N, Putnam RW, Yip AM, Frail D. Family practice patients’ adherence to statin medications. Can Fam Physician. 2007;53(12):2144–2145.
   PubMedGoogle Scholar
• Ye X, Gross CR, Schommer J, Cline R, St. Peter WL. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. Article. Clin Ther. 2007;29(12):2748–2757. doi:10.1016/j.clinthera.2007.12.022
   Web of Science ®Google Scholar
• Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Article. Clin Ther. 2008;30(11):2167–2179. doi:10.1016/j.clinthera.2008.11.012
   PubMed Web of Science ®Google Scholar
• Vinker S, Shani M, Baevsky T, Elhayany A. Adherence with statins over 8 years in a usual care setting. Am J Manag Care. 2008;14(6):388–392.
   Web of Science ®Google Scholar
• Latry P, Molimard M, Dedieu B, Couffinhal T, Bégaud B, Martin-Latry K. Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord. 2011;11:46. doi:10.1186/1471-2261-11-46
   PubMed Web of Science ®Google Scholar
• Wong MC, Jiang JY, Griffiths SM. Adherence to lipid-lowering agents among 11,042 patients in clinical practice. Int J Clin Pract. 2011;65(7):741–748. doi:10.1111/j.1742-1241.2011.02706.x
   Web of Science ®Google Scholar
• Wong MCS, Jiang JY, Yan BP, Griffiths SM. Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a Chinese population. Article. Clin Ther. 2011;33(5):617–628. doi:10.1016/j.clinthera.2011.04.019
   Web of Science ®Google Scholar
• Brogaard HV, Køhn MG, Berget OS, et al. Significant improvement in statin adherence and cholesterol levels after acute myocardial infarction. Dan Med J. 2012;59(9):A4509.
   Web of Science ®Google Scholar
• Cheetham TC, Niu F, Green K, et al. Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm. 2013;19(5):367–373. doi:10.18553/jmcp.2013.19.5.367
   PubMed Web of Science ®Google Scholar
• Christian JB, Rabatin V, Lowe KA. Adherence, persistence, and predictors associated with early niacin termination. Article. J Pharm Technol. 2013;29(4):178–185. doi:10.1177/875512251302900406
   Google Scholar
• Xie G, Zaman MJ, Myint PK, Liang L, Zhao L, Wu Y. Factors associated with compliance to lipid-lowering treatment in China. Eur J Prev Cardiol. 2013;20(2):229–237. doi:10.1177/2047487312438847
   PubMed Web of Science ®Google Scholar
• Cicero AF, Derosa G, Parini A, Baronio C, Borghi C. Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments. Atherosclerosis. 2014;235(1):81–83. doi:10.1016/j.atherosclerosis.2014.04.016
   Web of Science ®Google Scholar
• Halava H, Korhonen MJ, Huupponen R, et al. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities. Article. CMAJ. 2014;186(12):E449–E456. doi:10.1503/cmaj.131807
   Web of Science ®Google Scholar
• Gaisenok O, Martsevich S, Tripkosh S, Lukina Y. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry. Rev Port Cardiol. 2015;34(2):111–116. doi:10.1016/j.repc.2014.08.021
   Google Scholar
• Halava H, Westerlund H, Korhonen MJ, et al. Influence of retirement on adherence to statins in the insurance medicine all-Sweden total population data base. PLoS One. 2015;10(6):e0130901. doi:10.1371/journal.pone.0130901
   Web of Science ®Google Scholar
• Korhonen MJ, Halonen JI, Brookhart MA, et al. Childhood adversity as a predictor of non-adherence to statin therapy in adulthood. PLoS One. 2015;10(5):e0127638. doi:10.1371/journal.pone.0127638
   Web of Science ®Google Scholar
• Warren JR, Falster MO, Tran B, Jorm L. Association of continuity of primary care and statin adherence. PLoS One. 2015;10(10):e0140008. doi:10.1371/journal.pone.0140008
   Web of Science ®Google Scholar
• Korhonen MJ, Pentti J, Hartikainen J, Kivimäki M, Vahtera J. Somatic symptoms of anxiety and nonadherence to statin therapy. Int J Cardiol. 2016;214:493–499. doi:10.1016/j.ijcard.2016.04.003
   PubMed Web of Science ®Google Scholar
• Kronish IM, Ross JS, Zhao H, Muntner P. Impact of hospitalization for acute myocardial infarction on adherence to statins among older adults. Circ Cardiovasc Qual Outcomes. 2016;9(4):364–371. doi:10.1161/circoutcomes.115.002418
   Web of Science ®Google Scholar
• Tokgözoğlu L, Özdemir R, Altındağ R, et al. Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyol Dern Ars. 2016;44(1):53–64. doi:10.5543/tkda.2015.47041
   Web of Science ®Google Scholar
• Al-Foraih M, Somerset S. Factors affecting adherence to statins in hypercholesterolemic Kuwaiti patients: a Cross-Sectional Study. Med Princ Pract. 2017;26(1):35–40. doi:10.1159/000450644
   PubMed Web of Science ®Google Scholar
• Booth JN 3rd, Colantonio LD, Chen L, et al. Statin discontinuation, reinitiation, and persistence patterns among medicare beneficiaries after myocardial infarction: a Cohort Study. Circ Cardiovasc Qual Outcomes. 2017;10(10):e003626. doi:10.1161/circoutcomes.117.003626
   Web of Science ®Google Scholar
• Devaraj NK, Mohamed M, Hussein N. Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients. Med J Malaysia. 2017;72(3):157–164.
   PubMedGoogle Scholar
• Hickson RP, Robinson JG, Annis IE, et al. Changes in statin adherence following an acute myocardial infarction among older adults: patient predictors and the association with follow-up with primary care providers and/or cardiologists. J Am Heart Assoc. 2017;6(10):e007106. doi:10.1161/jaha.117.007106
   Web of Science ®Google Scholar
• Wawruch M, Zatko D, Wimmer G Jr, et al. Age-related differences in non-persistence with statin treatment in patients after a transient ischaemic attack. Clin Drug Investig. 2017;37(11):1047–1054. doi:10.1007/s40261-017-0559-3
   Web of Science ®Google Scholar
• Chung PW, Yoon BW, Lee YB, et al. Medication adherence of statin users after acute ischemic stroke. Eur Neurol. 2018;80(1–2):106–114. doi:10.1159/000493530
   Web of Science ®Google Scholar
• Do Nascimento R, Guerra AA Jr, Alvares J, et al. Statin use in Brazil: findings and implications. Curr Med Res Opin. 2018;34(10):1809–1817. doi:10.1080/03007995.2018.1451312
   PubMed Web of Science ®Google Scholar
• Haddad C, Hallit S, Salhab M, et al. Association between adherence to statins, illness perception, treatment satisfaction, and quality of life among Lebanese patients. Article. J Cardiovasc Pharmacol Ther. 2018;23(5):414–422. doi:10.1177/1074248418769635
   Web of Science ®Google Scholar
• Kriegbaum M, Lau SR. Medication non-adherence and uncertainty: information-seeking and processing in the Danish LIFESTAT survey. Res Social Adm Pharm. 2018;14(8):736–741. doi:10.1016/j.sapharm.2017.09.002
   Web of Science ®Google Scholar
• Ofori-Asenso R, Ilomaki J, Tacey M, et al. Switching, discontinuation, and reinitiation of statins among older adults. J Am Coll Cardiol. 2018;72(21):2675–2677. doi:10.1016/j.jacc.2018.08.2191
   Web of Science ®Google Scholar
• Chen ST, Huang ST, Shau WY, et al. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan. BMC Cardiovasc Disord. 2019;19(1):62. doi:10.1186/s12872-019-1032-4
   PubMed Web of Science ®Google Scholar
• Phan DQ, Duan L, Lam B, et al. Statin adherence and mortality in patients aged 80 years and older after acute myocardial infarction. J Am Geriatr Soc. 2019;67(10):2045–2049. doi:10.1111/jgs.16037
   PubMed Web of Science ®Google Scholar
• Waßmuth S, Rohe K, Noack F, Noutsias M, Treede H, Schlitt A. Adherence to lipid-lowering therapy in patients with coronary heart disease from the state of saxony-anhalt, Germany. Article. Vasc Health Risk Manag. 2019;15:477–483. doi:10.2147/VHRM.S197089
   PubMed Web of Science ®Google Scholar
• Bruckert E, Desamericq G, Khachatryan A, Ngo P, Gusto G, Sorio-Vilela F. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome. Rev Cardiovasc Med. 2020;21(4):643–650. doi:10.31083/j.rcm.2020.04.189
   Web of Science ®Google Scholar
• Seamon K, Sanfilippo F, Bulsara M, et al. Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study. Public Health Res Pract. 2020;30(1):1–9. doi:10.17061/phrp29121905
   Web of Science ®Google Scholar
• Shakarneh JK, Hallak HO, Awadallah HB, Al-Hamed DH, Khdour MR. Necessity and concerns about lipid-lowering medical treatments and risk factors for non-adherence: a cross-sectional study in Palestine. Int J Clin Pract. 2020;74(7):e13511. doi:10.1111/ijcp.13511
   Web of Science ®Google Scholar
• Ofori-Asenso R, Jakhu A, Curtis AJ, et al. A systematic review and meta-analysis of the factors associated with nonadherence and discontinuation of statins among people aged ≥65 years. J Gerontol A Biol Sci Med Sci. 2018;73(6):798–805. doi:10.1093/gerona/glx256
   PubMed Web of Science ®Google Scholar
• Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–1421. doi:10.1345/aph.1P150
   PubMed Web of Science ®Google Scholar
• Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005;7(1):4.
   PubMedGoogle Scholar
• Santos P. Challenge of health literacy in cardiovascular disease prevention. Curr Res Cardiol. 2018;5(special issue 4):18.
   Google Scholar
• Santos P, Nazare I, Martins C, Sa L, Couto L, Hespanhol A. As Normas de Orientacao Clinica em Portugal e os Valores dos Doentes. [The Portuguese Guidelines and Patients Values]. Acta Med Port. 2015;28(6):754–759. doi:10.20344/amp.6301
   Web of Science ®Google Scholar